Literature DB >> 15312865

Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure.

James O O'Neill1, James B Young, Claire E Pothier, Michael S Lauer.   

Abstract

OBJECTIVES: The study was done to determine the prognostic importance of frequent ventricular ectopy in recovery after exercise among patients with systolic heart failure (HF).
BACKGROUND: Although ventricular ectopy during recovery after exercise predicts death in patients without HF, its prognostic importance in patients with significant ventricular dysfunction is unknown.
METHODS: Systematic electrocardiographic data during rest, exercise, and recovery were gathered on 2,123 consecutive patients with left ventricular systolic ejection fraction <or=35% who were referred for symptom-limited metabolic treadmill exercise testing. Severe ventricular ectopy was defined as the presence of ventricular triplets, sustained or nonsustained ventricular tachycardia, ventricular flutter, polymorphic ventricular tachycardia, or ventricular fibrillation. The primary end point was all-cause mortality, with censoring for interval cardiac transplantation.
RESULTS: Of 2,123 patients, 140 (7%) had severe ventricular ectopy during recovery. There were 530 deaths (median follow-up among survivors 2.9 years). Severe ventricular ectopy during recovery was associated with an increased risk of death (three-year death rates 37% vs. 22%, hazard ratio [HR] 1.76; 95% confidence interval [CI] 1.32 to 2.34, p < 0.0001). After adjustment for ventricular ectopy at rest and during exercise, peak oxygen uptake, and other potential confounders, severe ventricular ectopy during recovery remained predictive of death (adjusted HR 1.48; 95% CI 1.10 to 1.97; p = 0.0089), whereas ventricular ectopy during exercise was not predictive of death in this cohort.
CONCLUSIONS: Severe ventricular ectopy during recovery after exercise is predictive of increased mortality in patients with severe HF and can be used as a prognostic indicator of adverse outcomes in HF cohorts.

Entities:  

Mesh:

Year:  2004        PMID: 15312865     DOI: 10.1016/j.jacc.2004.02.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

2.  Microvolt T-wave alternans, peak oxygen consumption, and outcome in patients with severely impaired left ventricular systolic function.

Authors:  Eiran Z Gorodeski; Daniel J Cantillon; Sachin S Goel; Elizabeth S Kaufman; David O Martin; Eileen M Hsich; Eugene H Blackstone; Michael S Lauer
Journal:  J Heart Lung Transplant       Date:  2009-05-13       Impact factor: 10.247

3.  Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies.

Authors:  Victor Lee; Dhanuka Perera; Pier Lambiase
Journal:  Heart Asia       Date:  2017-01-04

4.  Rest premature ventricular contractions on routine ECG and prognosis in heart failure patients.

Authors:  Vy-Van Le; Teferi Mitiku; David Hadley; Jonathan Myers; Victor F Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-01       Impact factor: 1.468

Review 5.  Utility of the exercise electrocardiogram testing in sudden cardiac death risk stratification.

Authors:  Marwan M Refaat; Mostafa Hotait; Zian H Tseng
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07       Impact factor: 1.468

6.  Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.

Authors:  Marwan M Refaat; Charbel Gharios; M Vinayaga Moorthy; Farah Abdulhai; Roger S Blumenthal; Miran A Jaffa; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2021-12-07       Impact factor: 24.094

7.  Prognostic implications of structural heart disease and premature ventricular contractions in recovery of exercise.

Authors:  Thomas Lindow; Magnus Ekström; Lars Brudin; Kristofer Hedman; Martin Ugander
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.